StockTipsArenaBeta

BUY Mankind Pharma Limited — Rakesh Bansal

BUYMankind Pharma Limited
Mankind Pharma share price target & all analyst calls

byRakesh BansalHorizon: Intraday27 Oct 2026, 9:30 am ISTvia CNBC Awaaz.

Entry₹2,435Inferred
Target₹2,520
Total upside +3.49% (call closed)
Stop loss₹2,400-1.44% risk
Exit₹2,520Target hit — time not yet verified
Target hit+3.49%0.00%upside left
Follow Rakesh Bansal for new calls(15% target hit, 95 closed calls)Get alertsWatch MANKIND for new buy/sell callsGet alertsSee 1 active Intraday call on MANKINDSee 17 active Intraday picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 27 Oct, 2:56 pm IST
4 supporting2 neutral0 opposing
Supports the BUY call (4)

Mankind Pharma Shares Jump Nearly 8% After Q2 Profit Rises 39%

NewsNdtv-Profit·27 Oct · today

(opens in new tab)

Mankind Pharma Q2 profit rises 38% to Rs 716 crore

NewsEt-Markets·27 Oct · today

(opens in new tab)

Mankind Pharma Q2 profit jumps 39% to ₹712 crore as revenue rises 17%

NewsCnbc-Tv18·26 Oct · today

(opens in new tab)

1 other SEBI-registered advisor has an active intraday BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·27 Oct · today

Neutral / worth noting (2)

Mankind Pharma Q2 Review: Export Momentum Continues; Systematix Maintains 'Hold'; Check Target Price

NewsNdtv-Profit·27 Oct · today

(opens in new tab)

Mankind Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·26 Oct · today

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Mankind Pharma

All analyst calls on Mankind Pharma

More from Rakesh Bansal

Every call and its outcome